Skip to main content

Search form

Search

Open menu

About us
Our research
Patient Engagement
- Why and how
- Patient Advisory Board
Partners
Newsroom
Contact

RADAR-CNS RADAR-base MyProjectPlaza

Welcome to RADAR-AD

Collaborative research that explores the potential of mobile and digital technologies to improve the assessment of Alzheimer’s Disease

About RADAR-AD

More about our research

More about our research

Alzheimer’s Disease

17 May 2019

Involving patients in research: the RADAR-AD Patient Advisory Board.

Read more

Patient engagement

Our partners

Learn more about us

Learn more about us

Subscribe to our newsletter

https://altoida.com/

https://www.alzheimer-europe.org/

https://www.amsterdamumc.nl/

https://www.cbg-meb.nl/

https://www.certh.gr/root.en.aspx

https://www.fraunhofer.de/en.html

https://www.janssen.com/neuroscience

https://ki.se/en/startpage

https://www.kcl.ac.uk/

https://www.lilly.com/

Https://www.lygature.org

https://www.novartis.com/

https://www.softwareag.com/nl/

https://www.takeda.com/

http://www.ox.ac.uk/

Co-leads on this project are Janssen Pharmaceutica and King’s College London

Funding statement

RADAR-AD receives funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 806999. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. See www.imi.europa.eu for more details.

Subscribe to our newsletter

And stay up to date about the latest news and developments.

Newsletter archive

Terms and conditions
Privacy Policy
Cookies Policy
Disclaimer

Close

RADAR-AD Newsletter

Email Address *

First Name

Last Name